Health Care·Health Care Equipment·$23.8B
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.32 | N/A | -35.74% |
| Revenue | N/A | N/A | N/A |
management commentary, guidance changes, and full analysis available with Pro.
| EPS | $0.32 | N/A | -35.74% |
| Revenue | N/A | N/A | N/A |
Tone: Defensive
Management expressed concerns about current market conditions impacting performance. They remain focused on strategic initiatives for future growth.
Management acknowledged the challenges faced during the quarter.
They emphasized a focus on long-term growth despite short-term setbacks.
There was no specific guidance provided for future quarters.
Dexcom's earnings report indicates a significant miss on EPS expectations, which may raise concerns among investors about the company's current performance. However, the stock saw a slight increase of 0.05%, suggesting that investors may be optimistic about the company's long-term strategy despite the disappointing earnings. The lack of revenue data and guidance leaves some uncertainty about future performance.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
CADENCE DESIGN SYS I
Apr 25, 2022